Heart Valve Disease Clinical Trials

37 recruitingLast updated: June 18, 2026

There are 37 actively recruiting heart valve disease clinical trials across 20 countries. Studies span Not Applicable, Phase 4, Phase 3. Top locations include Ann Arbor, Michigan, United States, New York, New York, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Heart Valve Disease Trials at a Glance

37 actively recruiting trials for heart valve disease are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Ann Arbor, New York, and Chicago. Lead sponsors running heart valve disease studies include Second Affiliated Hospital, School of Medicine, Zhejiang University, Assistance Publique - Hôpitaux de Paris, and TRiCares.

Browse heart valve disease trials by phase

Treatments under study

About Heart Valve Disease Clinical Trials

Looking for clinical trials for Heart Valve Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Valve Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Valve Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting
Not Applicable

EFS of the DUO System for Tricuspid Regurgitation

Tricuspid RegurgitationHeart Valve DiseasesTricuspid Valve Insufficiency+1 more
CroiValve Limited15 enrolled15 locationsNCT05913908
Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

CardiomyopathyCardiovascular DiseasesHeart Valve Diseases+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07617844
Recruiting
Not Applicable

CTSN Embolic Protection Trial

Acute Kidney InjuryCoronary Artery DiseaseDelirium+2 more
Icahn School of Medicine at Mount Sinai842 enrolled28 locationsNCT06027788
Recruiting
Not Applicable

Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery

Postoperative PainHeart Valve Disease
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital90 enrolled1 locationNCT07588230
Recruiting
Not Applicable

The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the Outcome of Patients Undergoing Surgical Cardiac Valve Replacement or Transcatheter Cardiac Valve Implantation.

Heart Valve DiseaseInfective Endocarditis (IE)
Region Skane1,300 enrolled5 locationsNCT07511673
Recruiting

AI Assisted Screening for VHD Using Routine Chest CT Scans

Heart Valve Diseases
Second Affiliated Hospital, School of Medicine, Zhejiang University3,000 enrolled3 locationsNCT07449130
Recruiting

Clinical Validation of Portable Electronic Stethoscope for Detecting VHD

Heart Valve Diseases
The University of Hong Kong125 enrolled1 locationNCT07568795
Recruiting
Not Applicable

The TRICURE EFS Study

Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
TRiCares15 enrolled9 locationsNCT06506942
Recruiting
Not Applicable

The TRICURE EU Pivotal Study

Cardiovascular DiseasesHeart Valve DiseaseTricuspid Valve Regurgitation
TRiCares80 enrolled8 locationsNCT06581471
Recruiting
Not Applicable

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Heart FailureCardiovascular DiseasesHeart Diseases+3 more
Cardiac Dimensions, Inc.300 enrolled92 locationsNCT03142152
Recruiting

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

Heart Valve DiseasesLeft Ventricular Dysfunction
Queen Mary University of London500 enrolled1 locationNCT05208567
Recruiting

GLS in Difficult CPB Weaning

Heart Valve DiseasesCoronary Artery BypassEchocardiography+3 more
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital213 enrolled2 locationsNCT07390903
Recruiting

Transpacific TAVR Registry

Heart Valve DiseasesAortic Valve Insufficiency
Duk-Woo Park, MD10,000 enrolled7 locationsNCT03826264
Recruiting
Not Applicable

Echocardiography in Nursing Home

Heart FailureHeart DiseasesHeart Valve Diseases
Nantes University Hospital1,050 enrolled1 locationNCT06445231
Recruiting

Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery

Myocardial IschemiaHeart Valve DiseasesAortic Diseases+3 more
Muhammet Talha Ceran, MD80 enrolled1 locationNCT07249424
Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Aortic Valve DiseaseHeart Valve DiseaseTricuspid Valve Regurgitation+11 more
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled15 locationsNCT07267117
Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Heart Valve DiseaseTAVIM-TEER+5 more
Montreal Heart Institute21,000 enrolled15 locationsNCT07213531
Recruiting
Not Applicable

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Heart TransplantMyocardial InfarctionCoronary Artery Disease+3 more
University of California, San Francisco516 enrolled5 locationsNCT05933083
Recruiting
Phase 3

Antagonization of Heparin With Protamine Sulfate After TAVI

Heart Valve DiseasesAortic Valve Stenosis
Assistance Publique - Hôpitaux de Paris940 enrolled1 locationNCT06215378
Recruiting
Phase 4

Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

Heart Valve DiseasesHeart Failure, CongestiveLeft Ventricle Remodeling+2 more
Vitor Emer Egypto Rosa60 enrolled1 locationNCT07099859